Ebola Bundibugyo: ECDC reports 6,686 confirmed cases and 3,226 deaths in DR Congo
The September 7 update reports 82 new confirmed cases and 51 deaths compared to the previous report, with 819 patients in isolation. No approved treatments or vaccines exist for this virus.
The Bundibugyo virus disease outbreak in the Democratic Republic of Congo continues to grow. On September 7, 2026, Congolese authorities reported 6,686 confirmed cases and 3,226 related deaths, with data updated as of September 6; the picture is reflected in the epidemiological update from the European Centre for Disease Prevention and Control (ECDC).
The figures in the update
Compared to the previous report, 82 new confirmed cases and 51 deaths have been recorded. There are 819 patients hospitalized in isolation and 1,563 people recovered among those who tested positive for the virus. New cases are concentrated in the provinces of Ituri, North Kivu and Haut-Uélé. 85.3 percent of identified contacts are under monitoring in the affected provinces (ECDC).
| Indicator | Value as of September 6, 2026 |
|---|---|
| Confirmed cases | 6,686 |
| Related deaths | 3,226 |
| Hospitalized in isolation | 819 |
| Recovered among positive cases | 1,563 |
| Change from previous report | +82 cases, +51 deaths |
| Contacts under monitoring | 85.3% |
Regarding the figures, it should be noted what they measure: these are confirmed cases, meaning laboratory-verified, and not estimates of actual spread. The share of contacts under monitoring is in turn calculated on identified contacts, not on the total of possible exposures. Both figures depend on field investigation capacity.
The institutional framework
On August 18, the Emergency Committee provided for under the International Health Regulations met for the second time, and the director-general of the World Health Organization confirmed the public health emergency of international concern (WHO, temporary recommendations). The qualification is not symbolic: it is the formal level that triggers the organization’s temporary recommendations to member states.
The most relevant detail from the response standpoint concerns the tools available. No approved treatments or vaccines exist against Bundibugyo virus, which is distinct from Ebola Zaire virus (ECDC, WHO, Disease Outbreak News). This is a difference in viral species, not a matter of nomenclature: products authorized for one are not automatically usable for the other.
No approved treatments or vaccines exist against Bundibugyo virus, which is different from Ebola Zaire virus.
Why geography matters
The three provinces where new cases are being recorded — Ituri, North Kivu, Haut-Uélé — indicate that transmission is not confined to a single health district. The number of patients hospitalized in isolation, 819, measures the concurrent burden on dedicated facilities, which is the operational figure most directly linked to the response capacity of local health systems.
What we do not know
The excerpts do not report the number of probable cases alongside confirmed ones, nor the distribution of deaths across provinces. They contain no data on healthcare personnel involved, on contact-tracing coverage in individual areas, or on the weekly trend of the curve. The date of the next ECDC update is not indicated.
The three sources used are institutional and independent of one another in terms of the issuing body — the European agency and two separate documents from the World Health Organization — but they ultimately share the Congolese national surveillance system as the source of the count.
← Archive · Front page · Past editorials · Report an error · Original article (in Italian)